The FSA Spy market buzz – 6 June 2025
Animal spirits run wild; Franklin Templeton is taking credit; EM banking revolution; Not all luxury is equal; Death of search and the AI machine; George Soros on wins and much more.
HEAD-TO-HEAD: JP Morgan versus UBS
FSA compares two China mixed asset products: the JP Morgan China Income Fund and the UBS Key Selection China Allocation Opportunity Fund.
Fees
The JP Morgan fund has an ongoing charge figure (OCF) of 1.85% and the annual expenses of the UBS fund are slightly higher at 1.91%.
The median OCF for Asia mixed asset products is 1.6%, according to FE Fundinfo data.
Ng sees no reason to be concerned about the fees charged by either fund.
“Investing in China’s markets tends to be more expensive and requires greater research resources than for other markets in Asia-Pacific,” he said.
Related Stories
Promoted Content
-
China’s post-pandemic growth gathers pace
-
Riding the wave of alternative income amongst HNWIs in APAC
-
Turning environmental hopes into investment reality
-
How can a sustainable approach also ensure you don’t compromise performance?
-
Despite headwinds, ESG continues to perform
-
Tap into Japan’s post-pandemic growth trends
-
Healthcare’s innovation shifts into high gear
-
The future of mobility
-
Ninety One: Finding opportunities in times of change
-
Accessing India’s tech future
